<DOC>
	<DOCNO>NCT01196702</DOCNO>
	<brief_summary>The purpose study discover difference surface marker B-cells ( antibody produce cell immune system ) Common Variable Immune Deficiency ( CVID ) relate CVID complications/treatment ( e.g . bronchiectasis , granulomatous disease , immunoglobulin treatment ) . The study hypothesis alter B-cell surface marker related CVID , complication treatment CVID .</brief_summary>
	<brief_title>Lymphocyte Immunophenotyping Common Variable Immunodeficiency</brief_title>
	<detailed_description>Common Variable Immune Deficiency ( CVID ) syndrome contain spectrum disorder result weaken immunity recurrent infection . The ESID ( European Society Immunodeficiencies ) CVID definition include patient mark decrease IgG ( least 2 standard deviation mean age ) . Patients must also disease onset age 2 year , absent isohaemagglutinins and/or response vaccine define cause hypogammaglobulinaemia must exclude . The Euroclass system classify CVID result European multicentre trial attempt develop consensus two exist classification scheme B-cell immunophenotyping . In paper show B-cell immunophenotype correlate coincidence clinical sequela suggest implement classify CVID give prognostic therapeutic information . However , yet show alteration B-cell immunophenotype result CVID cause treatment complication CVID ( e.g . immunoglobulin replacement therapy , granulomatous disease , bronchiectasis ) . The aim study show alteration B-cell immunophenotype cause CVID complication treatment . The study therefore compare CVID patient suitable control patient granulomatous disease , bronchiectasis long-term immunoglobulin therapy . A control group normal people also include ensure assay detect normality show differences normal people patient CVID .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Granuloma</mesh_term>
	<mesh_term>Common Variable Immunodeficiency</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>18 Competent consent Have diagnosis Common Variable Immunodeficiency , granulomatous disease , long term immunoglobulin bronchiectasis . Under 18 Unable consent . Medical problem could alter Bcell immunophenotype ( except diagnosis inclusion criterion ) /</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>common variable immunodeficiency</keyword>
	<keyword>granulomatous disease</keyword>
	<keyword>crohn disease</keyword>
	<keyword>bronchiectasis</keyword>
	<keyword>immunoglobulin replacement treatment</keyword>
	<keyword>B-cell immunophenotyping</keyword>
</DOC>